One year after becoming available for older Americans and pregnant women, receptive public opinion of respiratory syncytial ...

According to the CDC's latest wastewater viral activity data, nearly half the country is seeing concerning virus levels.

In most cases, adequate hydration and over-the-counter pain relievers can help manage your symptoms during the week or two it ...

More Americans believe in the effectiveness of vaccines developed to protect newborns and seniors against respiratory ...

But enrollment for all clinical studies of infant RSV vaccines is now on hold due to safety concerns, explained a Dec. 11 ...

A year after becoming available, vaccines to protect against RSV in newborns and older adults are being more widely accepted by the American public, according to a new health survey.

Research and development of a respiratory syncytial virus (RSV) vaccine for infants should continue, but with awareness of ...

RSVpreF vaccination is effective against RSV-related lower respiratory tract disease among adults aged 60 years or older.

The rise in perceived effectiveness for the RSV vaccine comes even though there has been no sign to date of a dreaded "tripledemic," the wave of flu, COVID-19, and RSV illnesses that filled ...

All participants had respiratory swabs collected and tested for RSV. Though previous trials have shown high VE, most trialed ...

Respiratory viruses typically experience their highest levels in the wintertime, and this year will likely be no different.

Flu cases are beginning to rise after a slow start to the season, with respiratory illnesses increasing nationwide in the ...